Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer

Published:2022-08-01 Issue:8 Volume:158 Page:933
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Asdourian Maria S.¹²,Shah Nishi²³,Jacoby Ted V.²⁴,Reynolds Kerry L.¹⁵,Chen Steven T.¹²

Affiliation:

1. Harvard Medical School, Boston, Massachusetts

2. Department of Dermatology, Massachusetts General Hospital, Boston

3. Virginia Commonwealth University School of Medicine, Richmond

4. University of Hawaii at Manoa John A. Burns School of Medicine, Honolulu

5. Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Boston

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2792449/jamadermatology_asdourian_2022_rv_220001_1659459473.10861.pdf

Reference90 articles.

1. Management of toxicities of immune checkpoint inhibitors.;Spain;Cancer Treat Rev,2016

2. Dermatologic reactions to immune checkpoint inhibitors: skin toxicities and immunotherapy.;Sibaud;Am J Clin Dermatol,2018

3. Immune-related adverse events associated with immune checkpoint blockade.;Postow;N Engl J Med,2018

4. Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer.;Hasan Ali;Oncoimmunology,2016

5. Diagnostic and therapeutic differences between immune checkpoint inhibitor-induced and idiopathic bullous pemphigoid: a cross-sectional study.;Molina;Br J Dermatol,2020

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Bullous Pemphigoid with Significant Infiltration of CD4-Positive T Cells during Treatment with Pembrolizumab, Accompanied by Pembrolizumab-Induced Multi-Organ Dysfunction;Diagnostics;2024-09-04

2. Review of T Helper 2-Type Inflammatory Diseases Following Immune Checkpoint Inhibitor Treatment;Biomedicines;2024-08-19

3. Sequential occurrence of primary cutaneous indeterminate cell histiocytosis after oesophageal cancer and subsequent bullous pemphigoid: a case report;British Journal of Hospital Medicine;2024-07-30

4. Arzneimittelexantheme unter Immun- und zielgerichteter onkologischer Therapie;Die Dermatologie;2024-05-21

5. The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases;American Journal of Clinical Dermatology;2024-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3